Multi‐Omic Analysis Reveals a Lipid Metabolism Gene Signature and Predicts Prognosis and Chemotherapy Response in Thyroid Carcinoma
Cancer Medicine · 2025-03 · 14 (6)
DOI: 10.1002/cam4.70819 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 22.03.2025. Verfasst von Yuqin Tu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Lipid Metabolism, Thyroid Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective
Lipid metabolic reprogramming is closely intertwined with the development and progression of thyroid carcinoma (TC); however, its specific mechanism remains elusive. This study aimed to investigate the association between lipid metabolism and TC progression.
Methods
We employed liquid chromatography‐mass spectrometry (LC/MS) for an untargeted metabolomics analysis, comparing 12 TC patients and 12 healthy controls (HC). Additionally, we conducted the screening of differentially expressed genes (DEGs) and identified differentially expressed lipid metabolism genes (LMGs). Multi‐omic findings related to lipid metabolism were integrated to establish a prognostic risk model. The resulting risk score stratified TC patients into high‐ and low‐risk groups. Overall survival (O.S.) was assessed using Kaplan–Meier (K–M) analysis. The immune landscape was evaluated using the CIBERSORT algorithm, and chemotherapeutic response was predicted utilizing the “pRRophetic” R package.
Results
Our metabolomic analysis revealed heightened lipid metabolic activity in TC, corroborated by similar findings in transcriptomic analysis. Multi‐omic analysis identified key LMGs (FABP4, PPARGC1A, AGPAT4, ALDH1A1, TGFA, and GPAT3) associated with fatty acids and glycerophospholipids metabolism. A novel risk model, incorporating these LMGs, confirmed significantly worse O.S. ( p = 0.0045) in the high‐risk group based on TCGA_THCA. Furthermore, high‐risk TC patients exhibited lower immune cell infiltration, and predictive outcomes indicated the efficacy of potential therapeutic drugs across risk groups.
Conclusion
This multi‐omic analysis underscores the potential utility of the lipid metabolism risk model in guiding clinical treatment and improving outcomes for TC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chongqing Medical University, Chongqing, China.
- Department of Clinical Laboratory, Chongqing General Hospital, Chongqing, China.
- North Sichuan Medical College, Nanchong, China.
- Department of Breast and Thyroid Surgery, Chongqing General Hospital, Chongqing, China.
Zitieren
APA
Tu, Y., Chen, Y., Mo, L., Yan, G., Xie, J., Ji, X., Chen, S., Niu, C., & Liao, P. (2025). Multi‐Omic Analysis Reveals a Lipid Metabolism Gene Signature and Predicts Prognosis and Chemotherapy Response in Thyroid Carcinoma. Cancer Medicine, 14(6). https://doi.org/10.1002/cam4.70819
Vancouver
Tu Y, Chen Y, Mo L, Yan G, Xie J, Ji X, et al. Multi‐Omic Analysis Reveals a Lipid Metabolism Gene Signature and Predicts Prognosis and Chemotherapy Response in Thyroid Carcinoma. Cancer Medicine. 2025;14(6). doi:10.1002/cam4.70819
BibTeX
@article{Tu2025,
author = {Tu, Yuqin and Chen, Yanchen and Mo, Linlong and Yan, Guiling and Xie, Jingling and Ji, Xinyao and Chen, Shu and Niu, Changchun and Liao, Pu},
title = {Multi‐Omic Analysis Reveals a Lipid Metabolism Gene Signature and Predicts Prognosis and Chemotherapy Response in Thyroid Carcinoma},
journal = {Cancer Medicine},
year = {2025},
volume = {14},
number = {6},
doi = {10.1002/cam4.70819}
}
EUVIMED